艾滋病合并卡氏肺孢子菌肺炎36例临床分析  

Clinical Analysis of Cartesian Pneumocystis Pneumonia AIDS Merged 36 Cases

作　　者：李泽峰[1] 

机构地区：[1]厦门大学附属第一医院杏林分院肺科,361022

出　　处：《中国继续医学教育》2016年第1期88-89,共2页China Continuing Medical Education

摘　　要：目的探讨艾滋病（AIDS）合并卡氏肺孢子菌肺炎（PCP）的诊断和治疗方法。方法回顾性分析我院2008年1月~2015年5月收治的36例艾滋病合并卡氏肺孢子虫肺炎患者的临床特征、实验室检查和胸部CT表现。结果 36例患者中咳嗽、咳痰36例,发热34例,胸闷气喘28例,呼吸衰竭12例;CD4＋T细胞〈50个/μl 26例。胸部CT示磨玻璃样阴影28例。治疗首选复方磺胺甲噁唑,34例好转,2例自动出院后失访。结论艾滋病合并卡氏肺孢子虫肺炎发病率高,病原体检出率相对低,目前仍以临床诊断为主。一旦临床考虑合并PCP,应尽早使用复方磺胺甲噁唑,以降低病死率。Objective To investigate HIV/AIDS（AIDS） merger cartesian pneumocystis pneumonia（PCP） in diagnosis and treatment. Methods A retrospective analysis of our hospital between January 2008 to May 2015,36 cases of HIV/AIDS merged pneumocystis carinii pneumonia in patients were with clinical features,laboratory examination and chest CT performance. Results 36 cases of cough,sputum 36 cases,fever 34 cases,bosom is frowsty asthma 28 cases,12 cases of respiratory failure. CD4 ＋ T cells 50 / μl 26 cases. Chest CT sample ground glass shadow 28 cases.Treatment of choice for compound sulfamethoxazole,34 cases improved,2 cases automatically lost to follow-up after discharge. Conclusion AIDS merged high rates of pneumocystis carinii pneumonia,pathogen detection rate is relatively low,still give priority to with clinical diagnosis. Once the clinical merger,PCP,should use compound sulfamethoxazole,as early as possible in order to reduce the case fatality rate.

关 键 词：艾滋病 卡氏肺孢子菌肺炎 复方磺胺甲噁唑 

分 类 号：R563.1[医药卫生—呼吸系统]